Titre : Infections à Vibrio

Infections à Vibrio : Questions médicales fréquentes

Termes MeSH sélectionnés :

Exsanguination
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Infections à Vibrio : Questions médicales les plus fréquentes", "headline": "Infections à Vibrio : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Infections à Vibrio : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-04", "dateModified": "2025-02-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Infections à Vibrio" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infections bactériennes à Gram négatif", "url": "https://questionsmedicales.fr/mesh/D016905", "about": { "@type": "MedicalCondition", "name": "Infections bactériennes à Gram négatif", "code": { "@type": "MedicalCode", "code": "D016905", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.400" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Choléra", "alternateName": "Cholera", "url": "https://questionsmedicales.fr/mesh/D002771", "about": { "@type": "MedicalCondition", "name": "Choléra", "code": { "@type": "MedicalCode", "code": "D002771", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.400.959.347" } } } ], "about": { "@type": "MedicalCondition", "name": "Infections à Vibrio", "alternateName": "Vibrio Infections", "code": { "@type": "MedicalCode", "code": "D014735", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bo Peng", "url": "https://questionsmedicales.fr/author/Bo%20Peng", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocontrol, Guangdong Key Laboratory of Pharmaceutical Functional Genes, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China. Electronic address: pengb26@mail.sysu.edu.cn." } }, { "@type": "Person", "name": "Fei Li", "url": "https://questionsmedicales.fr/author/Fei%20Li", "affiliation": { "@type": "Organization", "name": "College of Life Science and Technology, Beijing University of Chemical Technology, China; Clinical Laboratory center, Taian City Central Hospital, Taian 271000, China." } }, { "@type": "Person", "name": "Yigang Tong", "url": "https://questionsmedicales.fr/author/Yigang%20Tong", "affiliation": { "@type": "Organization", "name": "College of Life Science and Technology, Beijing University of Chemical Technology, China. Electronic address: tong.yigang@gmail.com." } }, { "@type": "Person", "name": "Jaime Martinez-Urtaza", "url": "https://questionsmedicales.fr/author/Jaime%20Martinez-Urtaza", "affiliation": { "@type": "Organization", "name": "Department de Genetica I de Microbiologia, Facultat de Biociencies, Universitat Autonoma de Barcelona, Barcelona, Spain." } }, { "@type": "Person", "name": "C H Ding", "url": "https://questionsmedicales.fr/author/C%20H%20Ding", "affiliation": { "@type": "Organization", "name": "Department of Medical Microbiology & Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Medullary cavity application of tranexamic acid to reduce blood loss in tibial intramedullary nailing procedures-a randomized controlled trial.", "datePublished": "2023-05-04", "url": "https://questionsmedicales.fr/article/37140597", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00264-023-05824-8" } }, { "@type": "ScholarlyArticle", "name": "Trauma Hybrid Operating Room (THOR) shortened procedure time in abdominopelvic trauma patients requiring surgery and interventional radiology procedures.", "datePublished": "2022-11-04", "url": "https://questionsmedicales.fr/article/36371314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.injury.2022.11.004" } }, { "@type": "ScholarlyArticle", "name": "Staged Repair of Primary Aortoesophageal Fistula.", "datePublished": "2023-05-05", "url": "https://questionsmedicales.fr/article/37144472", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348231173949" } }, { "@type": "ScholarlyArticle", "name": "A global perspective on gun violence injuries.", "datePublished": "2023-04-28", "url": "https://questionsmedicales.fr/article/37183087", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.injury.2023.04.050" } }, { "@type": "ScholarlyArticle", "name": "Whole Blood Trauma Resuscitation in Community Trauma Centers Confers Survival Benefit Over Component Therapy.", "datePublished": "2023-03-07", "url": "https://questionsmedicales.fr/article/36880710", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348231161669" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Infections bactériennes et mycoses", "item": "https://questionsmedicales.fr/mesh/D001423" }, { "@type": "ListItem", "position": 4, "name": "Infections bactériennes", "item": "https://questionsmedicales.fr/mesh/D001424" }, { "@type": "ListItem", "position": 5, "name": "Infections bactériennes à Gram négatif", "item": "https://questionsmedicales.fr/mesh/D016905" }, { "@type": "ListItem", "position": 6, "name": "Infections à Vibrio", "item": "https://questionsmedicales.fr/mesh/D014735" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Infections à Vibrio - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Infections à Vibrio", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Infections à Vibrio", "description": "Comment diagnostique-t-on une infection à Vibrio ?\nQuels tests sont utilisés pour identifier Vibrio ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer sans culture ?\nLes antécédents de voyage sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Infections à Vibrio", "description": "Quels sont les symptômes courants d'une infection à Vibrio ?\nLes infections à Vibrio causent-elles des éruptions cutanées ?\nY a-t-il des symptômes graves à surveiller ?\nLes symptômes varient-ils selon la souche de Vibrio ?\nLes symptômes apparaissent-ils rapidement ?", "url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Infections à Vibrio", "description": "Comment prévenir les infections à Vibrio ?\nLa cuisson des fruits de mer est-elle suffisante ?\nL'eau potable est-elle un risque ?\nLes voyages en zones à risque nécessitent-ils des précautions ?\nLes personnes à risque doivent-elles être plus prudentes ?", "url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Infections à Vibrio", "description": "Quel est le traitement principal pour les infections à Vibrio ?\nLes antibiotiques sont-ils toujours nécessaires ?\nComment la déshydratation est-elle traitée ?\nY a-t-il des traitements préventifs ?\nLes probiotiques aident-ils dans le traitement ?", "url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Infections à Vibrio", "description": "Quelles sont les complications possibles des infections à Vibrio ?\nLes infections cutanées peuvent-elles s'aggraver ?\nY a-t-il un risque de septicémie ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Infections à Vibrio", "description": "Quels sont les principaux facteurs de risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes maladies chroniques augmentent-elles le risque ?\nLa saison influence-t-elle le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une infection à Vibrio ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures de selles et des tests sérologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Vibrio ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des cultures bactériennes et des tests PCR sont couramment utilisés." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques orientent le diagnostic, mais des tests sont nécessaires." } }, { "@type": "Question", "name": "Peut-on diagnostiquer sans culture ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des méthodes moléculaires comme la PCR peuvent être utilisées sans culture." } }, { "@type": "Question", "name": "Les antécédents de voyage sont-ils importants ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents de consommation de fruits de mer ou de baignade en eau contaminée sont cruciaux." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une infection à Vibrio ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, vomissements, douleurs abdominales et fièvre." } }, { "@type": "Question", "name": "Les infections à Vibrio causent-elles des éruptions cutanées ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Certaines souches peuvent provoquer des infections cutanées, surtout après exposition à l'eau." } }, { "@type": "Question", "name": "Y a-t-il des symptômes graves à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes graves incluent déshydratation sévère et choc septique, nécessitant une attention médicale." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la souche de Vibrio ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la souche, comme Vibrio cholerae ou Vibrio parahaemolyticus." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures suivant l'infection." } }, { "@type": "Question", "name": "Comment prévenir les infections à Vibrio ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer des fruits de mer crus et lavez-vous les mains régulièrement." } }, { "@type": "Question", "name": "La cuisson des fruits de mer est-elle suffisante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cuire les fruits de mer à des températures appropriées tue les bactéries Vibrio." } }, { "@type": "Question", "name": "L'eau potable est-elle un risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'eau non traitée peut être contaminée, évitez de boire de l'eau non purifiée." } }, { "@type": "Question", "name": "Les voyages en zones à risque nécessitent-ils des précautions ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est conseillé de prendre des précautions alimentaires et d'hygiène lors de voyages." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles être plus prudentes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées doivent éviter les fruits de mer crus et les eaux contaminées." } }, { "@type": "Question", "name": "Quel est le traitement principal pour les infections à Vibrio ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la réhydratation, souvent accompagné d'antibiotiques si nécessaire." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas toujours nécessaires, surtout pour les infections légères." } }, { "@type": "Question", "name": "Comment la déshydratation est-elle traitée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation est traitée par des solutions de réhydratation orale ou intraveineuse." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des vaccins existent pour certaines souches, mais leur utilisation est limitée." } }, { "@type": "Question", "name": "Les probiotiques aident-ils dans le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale, mais leur efficacité varie." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des infections à Vibrio ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la déshydratation sévère, le choc septique et des infections systémiques." } }, { "@type": "Question", "name": "Les infections cutanées peuvent-elles s'aggraver ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections cutanées peuvent s'aggraver et nécessiter des soins médicaux urgents." } }, { "@type": "Question", "name": "Y a-t-il un risque de septicémie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches de Vibrio peuvent provoquer une septicémie, surtout chez les personnes vulnérables." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes à risque." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications nécessitent une prise en charge médicale rapide, souvent en milieu hospitalier." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'exposition à des eaux contaminées." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées et immunodéprimées sont plus susceptibles de développer des infections graves." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies chroniques comme le diabète augmentent le risque d'infections à Vibrio." } }, { "@type": "Question", "name": "La saison influence-t-elle le risque d'infection ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'infection augmente pendant les mois chauds, favorisant la prolifération de Vibrio." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions où Vibrio est endémique augmente le risque d'infection." } } ] } ] }

Sources (34 au total)

Medullary cavity application of tranexamic acid to reduce blood loss in tibial intramedullary nailing procedures-a randomized controlled trial.

Studies have shown an average postoperative hidden blood loss (HBL) of 473.29 ml and an average Hb loss of 16.71 g/l after intramedullary nailing. Reducing HBL has become a primary consideration for o... Patients with only tibial stem fractures who visited the study clinic between December 2019 and February 2022 were randomized into two groups using a computer-generated form. Two grams of tranexamic a... Ninety-seven patients (47 in the TXA group and 50 in the NS group) were analyzed; the TBL (252.10 ± 10.05 ml) and HBL (202.67 ± 11.86 ml) in the TXA group were significantly lower than the TBL (417.03... The combination of intravenous and topical TXA reduces blood loss after intramedullary nailing of tibial fractures without increasing the incidence of thrombotic events....

Trauma Hybrid Operating Room (THOR) shortened procedure time in abdominopelvic trauma patients requiring surgery and interventional radiology procedures.

Abdominopelvic injuries are common, and bleeding occurring in both cavities requires various bleeding control techniques i.e., laparotomy, angiographic embolization (AE), and orthopedic fixation. Henc... A pre-post intervention study of abdominopelvic injury patients requiring both surgery and interventional radiology (IR) procedures for bleeding control from January 2015 to May 2020 was conducted. Th... Ninety-one abdominopelvic trauma patients were identified during the study period, 56 patients in pre-THOR group and 35 patients in THOR group. Distribution of injuries was similar in both groups (59 ... THOR eliminated transit time, resulting in shorter procedure time in abdominopelvic trauma patients requiring bleeding-control intervention. Although overall mortality reduction could not be demonstra...

A global perspective on gun violence injuries.

Civilian gunshot violence is a growing public health issue on a global scale. Treatment of patients with gunshot injuries is based on algorithms derived from military studies, but the distinct differe... There are important differences in the care of gunshot victims across the globe; some countries provide advanced interventions in the field and others deliver basic support until transport to a higher... Control of exsanguinating hemorrhage is a key priority for gunshot injuries. Military doctrine has evolved to prioritize exsanguination over airway or breathing as the critical first step. The X-ABC p... The need for abdominal closure after exploratory laparotomy, definitive fracture treatment, and other treatment all contribute to length of stay for gunshot injured patients. Optimizing stabilization ... There are growing numbers of mass-casualty gunshot events, which require consideration of how to organize and use resources for treatment, including staff, operating room access, blood products, and o...

O blood type is not associated with worse coagulopathy or outcome in exsanguinating trauma.

Despite improving understanding of trauma-induced coagulopathy (TIC), mortality and morbidity due to exsanguinating trauma remain high. Increased complications due to hemorrhage have been reported in ... An urban level 1 adult trauma center registry was retrospectively queried. Patients receiving ≥6 units of pRBC within 4 ​h of presentation were included. Patient demographics, admission labs and outco... 562 patients were identified. There were no significant differences in demographics, admission labs, or outcome between different ABO groups. After adjustment, Type A patients were more likely to be h... No outcome or mortality differences were seen between ABO types, therefore factors other than vWF expression should be considered to explain coagulopathy in trauma patients....

Tranexamic acid can reduce blood loss in adolescent scoliosis surgery: a systematic review and meta-analysis.

Tranexamic acid (TXA) has been widely used in orthopedic surgery, but its efficacy in adolescent scoliosis (AS) surgery remains unclear in the literature. The purpose of this systematic review and met... English and Chinese electronic databases including PubMed, Web of Science, Embase, Cochrane, CNKI, and Wan Fang database were searched to identify the relevant literature up until August 2022. The pri... Twelve studies (795 participants) were included in the meta-analysis for intraoperative blood loss during surgery. The results suggest that TXA can reduce the intraoperative blood loss of the patients... The meta-analysis of the data reveals that TXA usage is associated with a significant reduction in intraoperative and total blood loss, a lower risk of transfusion, and a non-significant change in pos...

Comparison of the total and hidden blood loss in patients undergoing single-level open and unilateral biportal endoscopic transforaminal lumbar interbody fusion: a retrospective case control study.

This study aimed to compare total blood loss (TBL) and hidden blood loss (HBL) in patients undergoing single-level open transforaminal lumbar interbody fusion (O-TLIF) and unilateral biportal endoscop... A total of 53 patients who underwent ULIF and 53 patients who underwent O-TLIF from March 2020 to July 2022 were retrospectively reviewed. The Nadler's formula was employed to estimate the patient's b... TBL and measured blood loss (MBL) in ULIF group (326.86 ± 223.45 ml, 99.00 ± 72.81 ml) was significantly lower than O-TLIF group (427.97 ± 280.52 ml, 270.66 ± 102.34 ml). Nevertheless, the HBL in ULIF... Perioperative HBL should not be neglected in patients undergoing ULIF or O-TILF, as it accounts for a large percentage of TBL in both groups. ULIF is associated with lower TBL and MBL, postoperative a...

Anticoagulants and fracture morphology have a significant influence on total blood loss after proximal femur fractures.

Blood loss after proximal femoral fractures is an important risk factor for postoperative outcome and recovery. The purpose of our study was to investigate the total blood loss depending on fracture t... A retrospective single center study including 1478 patients treated operatively for a proximal femoral fracture between January 2016 and June 2020 at a level I trauma center. Patient data, surgical pr... One thousand four hundred seventy-eight mainly female patients were included in the study (mean age: 79.8 years) comprising 667 femoral neck fractures, 704 pertrochanteric- and 107 subtrochanteric fra... Hidden blood loss is underestimated. Anticoagulant use, fracture type, gender and BMI influence the total blood loss. Hemoglobin levels should be monitored closely. Within 48 h there was no increased ...